Abstract
Background Anxiety symptoms have variable prevalence rate of 26.3% to 50.4% in schizophrenic patients compared to 28.8% for general population. Some atypical antipsychotics (Quetiapine, Olanzapine) are effective in reducing anxiety in patients with schizophrenia or schizoaffective disorders. Objective The purpose of this preliminary study was to compare the efficacy of typical and atypical antipsychotics in reducing anxiety in patients diagnosed with schizophrenia and schizoaffective disorder hospitalized in Arad between 2013- 2014. Methods Considering the treatment, 63subjects patients were divided in two groups: T1 (treated with Olanzapine, Quetiapine) and T2 (treated with Haloperidolum, Risperidone, Aripiprazol). Results After treatment, the level of anxiety is reduced with significant improvement of total score of PANSS; the effect is higher in group T2 compared to T1. Before treatment, anxiety is positively correlated with total score of PANSSN (r=.285; p=0.010), PANSST (r=.260; p=0.040) and total score of HAM-D (r=.455; p Conclusions Various treatments are successful in reducing anxiety in psychotic patients. This conclusion is confirm duet our results: in group T2 the treatment has a higher effect on anxiety and lower size effect on intelligence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
